Stock INM INMED PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News InMed Pharmaceuticals Inc.

Equities

INM

CA4576376012

Market Closed - Nasdaq
Other stock markets
 21:30:01 01/05/2024 BST 		5-day change 1st Jan Change
0.2619 USD +0.70% Intraday chart for InMed Pharmaceuticals Inc. -4.07% -37.04%
04-18 InMed Pharmaceuticals Inc. Appoints David G. Morgan to its Scientific Advisory Board CI
04-04 InMed Pharmaceuticals Inc. Announces Additional Preclinical Data Demonstrating INM-901'S Positive Pharmacological Effects in the Potential Treatment of Alzheimer's Disease CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board
NE
InMed Pharmaceuticals Inc. Appoints David G. Morgan to its Scientific Advisory Board
CI
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
NE
InMed Pharmaceuticals Inc. Announces Additional Preclinical Data Demonstrating INM-901'S Positive Pharmacological Effects in the Potential Treatment of Alzheimer's Disease
CI
InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies
NE
InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
NE
InMed Pharmaceuticals Inc. Provides Update on Pharmaceutical Development Programs
CI
InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
NE
InMed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
InMed Pharmaceuticals Inc. Announces Chief Financial Officer Changes, Effective February 20, 2024
CI
InMed Pharmaceuticals Inc. Announces Executive Changes, Effective February 20, 2024
CI
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
NE
Transcript : InMed Pharmaceuticals Inc. - Special Call
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET
NE
InMed Pharmaceuticals Provides Business Update and Milestones for 2024
NE
InMed Announces Results of 2023 Annual General Meeting
NE
Transcript : InMed Pharmaceuticals Inc. - Shareholder/Analyst Call
Inmed Pharmaceuticals Inc. Announces the Launch of Inm-089
CI
InMed Expands its Pharmaceutical Pipeline with INM-089 targeting the treatment of Age-Related Macular Degeneration
NE
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INM Stock
  4. News InMed Pharmaceuticals Inc.